Radiation therapy in renal cell carcinoma.

[1]  I. Kaplan,et al.  Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) , 2018, Cancer.

[2]  V. Tombolini,et al.  Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review , 2018, Neoplasia.

[3]  B. Slotman,et al.  Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach , 2017, Nature Reviews Urology.

[4]  B. Esmaeli,et al.  Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual. , 2017, Ophthalmic plastic and reconstructive surgery.

[5]  V. Tombolini,et al.  New Approaches in Glioblastoma Multiforme: The Potential Role of Immune- check Point Inhibitors. , 2017, Current Cancer Drug Targets.

[6]  N. Lawrentschuk,et al.  Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  H. Onishi,et al.  Consensus statement Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma , 2016 .

[8]  P. Brown,et al.  Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. , 2016, Journal of neurosurgery. Spine.

[9]  E. Lam,et al.  Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT) , 2015, Radiation oncology.

[10]  M. Schluchter,et al.  Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  C. Marchetti,et al.  Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors , 2015, Journal of immunology research.

[12]  M. Bader,et al.  Single fraction radiosurgery for the treatment of renal tumors. , 2015, The Journal of urology.

[13]  N. Corcoran,et al.  Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: A systematic review , 2015, Acta oncologica.

[14]  M. Fehlings,et al.  Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture. , 2014, Journal of neurosurgery. Spine.

[15]  V. Khoo,et al.  Radiotherapy for renal-cell carcinoma. , 2014, The Lancet. Oncology.

[16]  R. Weichselbaum,et al.  Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma , 2013, American journal of clinical oncology.

[17]  I. Kaplan,et al.  A Phase 1 Dose-Escalation Study of Robotic Radiosurgery in Inoperable Primary Renal Cell Carcinoma , 2013 .

[18]  J. Mechalakos,et al.  Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[19]  K. Rosenzweig,et al.  Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. , 2011, International journal of radiation oncology, biology, physics.

[20]  B. Kavanagh,et al.  Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control , 2010, Radiation oncology.

[21]  I. Kaplan,et al.  Results of a Phase I Dose Escalation Study of Stereotactic Radiosurgery for Primary Renal Tumors , 2010 .

[22]  M. Rafi,et al.  Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  M. Bilsky,et al.  Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  S Richardson,et al.  The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT) , 2007, Biomedical imaging and intervention journal.

[25]  G. Barnett,et al.  Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. , 2006, Journal of neurosurgery.

[26]  H. Blomgren,et al.  A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma , 2006, Acta oncologica.

[27]  Sten Nilsson,et al.  Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  S. Campbell,et al.  Metastatic renal cell carcinoma , 2003, Current treatment options in oncology.

[29]  D. Kondziolka,et al.  Stereotactic radiosurgery for brain metastasis from renal cell carcinoma , 1999, Cancer.

[30]  A. Haimovitz-Friedman,et al.  Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis , 1994, The Journal of experimental medicine.

[31]  B. Werf-Messing,et al.  Carcinoma of the kidney , 1973 .

[32]  R. Finney.  The value of radiotherapy in the treatment of hypernephroma--a clinical trial. , 1973, British journal of urology.

[33]  P. Iversen,et al.  A randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. A study by the Copenhagen Renal Cancer Study Group. , 1987, Scandinavian journal of urology and nephrology.

[34]  O. Alfthan,et al.  Preoperative irradiation in the treatment of renal adenocarcinoma. , 1977, Scandinavian journal of urology and nephrology.